Gp100 (17-25)
Gp100 (17-25) is an immunogenic peptide. gp100 (17-25) can generate tumor-specific HLA-A3-restricted T lymphocytes. gp100 (17-25) can be used for melanoma research[1].
Product Specifications
Target
Others
Related Pathways
Others
Field of Research
Cancer
Smiles
O=C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@@H](C(C)C)C(NCC(N[C@@H](C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N
Molecular Formula
C38H70N10O11
Molecular Weight
843.02
References & Citations
[1]Castelli C, et al. Immunogenicity of the ALLAVGATK (gp100[17-25]) peptide in HLA-A3.1 melanoma patients. Eur J Immunol. 1998 Apr;28 (4) :1143-54.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P11426/
Scientific Category
Peptides
Clinical Information
No Development Reported
CAS Number
[184297-65-2]
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
